FDA Approves Xatmep (methotrexate) Oral Solution

Denver, April 26, 2017 — Silvergate Pharmaceuticals, Inc. leaders in the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration (FDA) approved Xatmep...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news